December 20, 2005: Baxter Names Steven Caffé Vice President Global Regulatory Affairs and Medical Vigilance
December 16, 2005: Baxter Provides Support To 100,000 Lives Campaign
December 13, 2005: FDA Class I Classification Given to Baxter's September 2005 Urgent Product Recall for Meridian Hemodialysis Instrument
December 12, 2005: Baxter Launches First Sevoflurane in China and Announces Phased Launch in Other Countries in 2006
December 6, 2005: Baxter Names Robert H. Armstrong Vice President, Research & Development, Medical Devices
December 5, 2005: Jeffrey Modell Foundation Opens Diagnostic Center for Primary Immunodeficiencies at Emory Children's Center in Atlanta
December 5, 2005: Halozyme Therapeutics and Baxter Healthcare Corporation Announce FDA Approval of Hylenex
November 23, 2005: KIOVIG, Baxter's New IVIG Product Receives Unanimous Positive Opinion in Europe as Replacement Therapy for Immunodeficiencies
November 22, 2005: Honor Society of Nursing Recognizes Researcher for Relief of Cancer Treatment Side Effects
November 18, 2005: Baxter Announces FDA Clearance Allowing Blood Centers to Pursue Use of AMICUS-Collected Platelets Stored Up to Seven Days
November 17, 2005: Baxter and Kuros Announce Product License and Collaboration Agreement
November 16, 2005: Baxter Names Cheryl White V.P. Quality
November 16, 2005: Baxter Funds Pension Plan and Retires Debt With Earnings Repatriated Under American Jobs Creation Act
November 16, 2005: Baxter Boosts Awareness of AAT Deficiency During World COPD Day
November 15, 2005: Baxter Declares Annual Dividend
November 15, 2005: Baxter Announces Plans to Voluntarily Withdraw 6060 Multi-Therapy Infusion Pump
November 11, 2005: Baxter Inducts Blood Donors From 13 Blood Centers Across the Country Into Donation Hall of Fame
November 2, 2005: Preliminary Results Suggest Augmentation Therapy May Slow Decline of Health-Related Quality of Life in Patients with AAT Deficiency
October 27, 2005: National Hemophilia Foundation Grants 2005 Awards Under Baxter-Sponsored NHF Clinical Fellowship Program
October 24, 2005: Baxter Selected to Dow Jones Sustainability Index for Seventh Consecutive Year
October 20, 2005: Baxter Reports Financial Results for the Third Quarter
October 18, 2005: Baxter International Foundation Awards Nearly $1.3 Million in Grants to Help Improve Access to Healthcare for Underserved Populations
October 17, 2005: FDA Approves Baxter's FLEXBUMIN, the First and Only Albumin Solution to be Packaged in a Flexible Container
October 13, 2005: Baxter Announces Additional Actions by U.S. FDA Concerning COLLEAGUE Infusion Pumps
September 29, 2005: Baxter Announces Collaborations to Develop Longer Acting Forms of Blood Clotting Factors
September 27, 2005: Baxter Announces Plan to Repatriate Approximately $2.0 Billion Under the American Jobs Creation Act
September 26, 2005: Baxter Announces the U.S. Launch of Gammagard Liquid 10% For Patients With Primary Immunodeficiency Disorders
September 23, 2005: Baxter Prevails in Sevoflurane Patent Dispute
September 21, 2005: Baxter's February 2005 Corrective Action for COLLEAGUE Infusion Pump Receives FDA Class I Designation
September 15, 2005: AABB and Baxter Sponsor First Annual Blood Collectors Week
September 14, 2005: Baxter to Present at Banc of America 35th Annual Investment Conference
September 7, 2005: Baxter to Present at Bear Stearns 18th Annual Healthcare Conference
September 1, 2005: Baxter Supports Hurricane Katrina Relief Efforts
August 29, 2005: Baxter Receives FDA Approval for Ceftriaxone Injection Offered in Frozen, Premixed Ready-to-Use Containers
August 11, 2005: Expanded Clinical Data for ADVATE Confirm Safety and Efficacy in Hemophilia Patients
August 8, 2005: Halozyme Therapeutics and Baxter Healthcare Corporation Expand Relationship to Include European Union
July 21, 2005: Baxter Reports Earnings Per Share of $0.51 and 8 Percent Increase in Sales in Second Quarter
July 21, 2005: Baxter Receives Notice From FDA Classifying Colleague Infusion Pump March 2005 Corrective Action as a Class I Recall
July 21, 2005: Baxter Healthcare Corporation Announces Agreement to Distribute and Promote Gambro's Hemodialysis Instruments
June 8, 2005: Baxter Testifies Before Congress About Business Benefits of Climate Change Initiatives
May 26, 2005: The Baxter International Foundation Awards Grants in Six Countries to Improve Access to Healthcare
May 25, 2005: Baxter Executives Discuss Financial Outlook and Strategic Priorities at Investor Conference
May 24, 2005: Data Presented From the Largest AAT Deficiency Screening Program in Patients with COPD Identifies Risk For Hereditary Emphysema
May 3, 2005: Baxter Executives Highlight Significant Change and Progress Made Over Last Year at Company's Annual Stockholder Meeting
May 2, 2005: FDA Approves Baxter's GAMMAGARD Liquid 10% for Patients with Primary Immunodeficiency Disorders
April 21, 2005: Baxter Reports 20 Percent Increase in First Quarter Earnings, with EPS of $0.36 and Sales Growth of 8 Percent
April 13, 2005: Baxter Receives Marketing Approval from Australia's Therapeutic Goods Administration for ADVATE to Treat Haemophilia A
April 13, 2005: CSC Wins $19.6 Million Contract for Advanced Development of Chemical Nerve Agent Treatment
April 12, 2005: Baxter Names Dr. Sarah Prichard as Vice President of Global Medical Affairs for Renal Business
April 11, 2005: Dr. David L. Sackett Selected for the Prestigious Baxter International Foundation Health Services Research Prize
April 11, 2005: Baxter and Cangene Announce U.S. FDA Approval of Liquid Formulation of WinRho® SDF
April 7, 2005: Baxter's ALYX System Wins 2005 Medical Design Excellence Award
March 31, 2005: Baxter International Inc. Names Peter Hellman to Board of Directors
March 30, 2005: Halozyme Therapeutics and Baxter Healthcare Corporation Expand Relationship to Include Development and Supply Agreement
March 28, 2005: Baxter Assumes Marketing and Distribution Rights for Cangene's WinRho SDF in the U.S.
March 23, 2005: Baxter Announces Two Key Executive Appointments
March 21, 2005: Baxter International Inc. Names Blake Devitt to Board of Directors
March 14, 2005: Baxter to Restate 2001 Through 2003 Financial Statements to Correct Income Tax Accounting Errors
March 8, 2005: Baxter and Its Foundation Contribute More Than $14 Million in 2004 to Communities in Need
March 3, 2005: Baxter Reports Strong Momentum for ADVATE After First Year on the European Market
March 1, 2005: Baxter and The American National Red Cross Agree to Terminate Contract Manufacturing Arrangement for Plasma Products
February 24, 2005: EPA Recognizes Baxter Healthcare Corporation as a Corporate Leader of its Performance Track Program
February 14, 2005: Baxter Receives 510k Clearance from U.S. FDA for Wireless Connectivity and Monitoring for COLLEAGUE CX Infusion Pump
February 9, 2005: Michigan's Henry Ford Health System Wins Prestigious Foster G. McGaw Prize for Excellence in Community Service
February 3, 2005: Baxter and Cerus Sign New Agreement to Commercialize INTERCEPT Blood System
January 27, 2005: Baxter Reports Fourth Quarter Results In Line With Expectations and Provides Financial Guidance for Full-Year 2005
January 10, 2005: Baxter Confirms Fourth Quarter Earnings Guidance, Excluding Non-Cash Charges
Print this page
